Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing evaluation of Idavir peritoneal dialysis solution in adult CAPD patients
ChiCTR2100044720Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of Idavir in end-stage kidney disease (ESKD) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: Ultrafiltration capacity and Kt/V (urea clearance index). Started May 2020; status: recruiting.
02
Drugs
Idavir
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2100044720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044720.